Although most people think of selective serotonin reuptake inhibitors (SSRIs) when discussing antidepressants, serotonin and norepinephrine reuptake inhibitors (SNRIs) also play a critical role in managing major depressive disorder and...
On December 18, 2023, researchers published a study in Cancer, a journal of the American Cancer Society, evaluating the safety, feasibility, and efficacy of psilocybin-assisted group therapy to manage...
The pharmaceutical industry has witnessed a significant rise in the utilization of specialty drugs in recent years, prompting a need for improved cost management and a streamlined patient experience. Specialty drugs, characterized by their...
On the tail of their win as the first FDA-approved CRISPR-based gene editing therapy, Vertex Pharmaceuticals announced the results of a phase 2 clinical trial for VX-548, a non-opioid pain management...
On December 4, 2023, Roche revealed that it entered into definitive merger agreements with Carmot Therapeutics. According to the company’s press release, it will acquire Carmot and its gamut of...
Personalized medicine is vital because it streamlines clinical decision-making through genetic tests or biomarkers. Essentially, personalized care lets caregivers feel more confident that a patient will respond to a specific drug or be...
Earlier this week, the United States Food and Drug Administration (FDA) published a drug safety communication warning patients about potentially life-threatening side effects linked to levetiracetam...
On November 8, 2023, the United States Food and Drug Administration (FDA) approved Eli Lilly’s newest weight loss drug, Zepbound. The newly approved drug uses the same active ingredient as...
On November 3, 2023, the New York Times broke a story analyzing the role of Ozempic and other weight loss drugs in mental health or psychiatric care. Upon reaching out to 13 psychiatric departments at...
Throughout the past few decades, the healthcare industry has seen the emergence of a new class of treatments: nutraceuticals. A cross between nutrition and pharmaceuticals, the term nutraceutical was coined by Stephen DeFelice, MD, in...
Yesterday, the New England Journal of Medicine published the results of a randomized study, which revealed that semaglutide can help manage heart failure symptoms in obese patients with preserved...
Last week, Abbott announced plans to acquire Bigfoot Biomedical in the third quarter of 2023. If successful, this acquisition could significantly enhance Abbott’s diabetes management portfolio,...
Despite having multiple tools and resources to minimize the transmission of human immunodeficiency virus (HIV), the growing rate of drug resistance has forced scientists and medical professionals to explore viral mutations more...
On August 2, 2023, Altogen Biosystems announced and launched a new targeted reagent that can deliver biomolecules to the lungs, treating pulmonary diseases. According to the announcement, the drug has...
As the popularity of weight management drugs, including Ozempic, continues to rise, clinicians and healthcare professionals need a guide to the obesity drug landscape. The nuanced field of weight management continues to become more and...
A phase 2 clinical trial published in the New England Journal of Medicine revealed that retatrutide, Eli Lilly’s newest weight loss drug, helped patients achieve a 17.5% weight reduction in 24...
Adding to the arsenal of tools providers have to manage type 2 diabetes (T2D), the FDA has approved a new pediatric medication for managing the condition. The approval of Jardiance and Synjardy to...
Compounded forms of semaglutide have been linked to adverse events, leading to FDA-issued warnings. As a result, the FDA recommends that patients avoid compounded semaglutide whenever the approved...
Gaining popularity from celebrity endorsements and public speculation, Ozempic has become a staple weight loss drug in the United States. However, researchers speculate that the medication could...
The drug development process is a notably tricky component of the pharmaceutical industry, accounting for the most time and money required to get a drug to market. Across the United States, the average spending on drug development is...
